Clinical & Laboratory Haematology

Editorial
pp. 147-147(1)

Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders
pp. 148-171(24)
Authors: BENCH, A. J.; ERBER, W. N.; SCOTT, M. A.

Audit of correction of high INR in an anticoagulation clinic
pp. 172-176(5)
Authors: HIRRI, H. M.; GREEN, P. J.

Japanese collaborative study for fibrinogen assay: variability of the fibrinogen assay between different laboratories does not improve when a common calibrator is used
pp. 177-183(7)
Authors: TAKAMIYA, O.; HANDO, S.; TEKONDO, M.; BANDO, S.; OHKURA, M; NEGORO, T.; YOSHIDA, T.; HIGASHI, K.; OHNUMA, O.; KUBOTA, K.; TATSUMI, N.

Molecular and haematological characterization of compound Hb E/Hb Pyrgos and Hb E/Hb J-Bangkok in Thai patients
pp. 184-189(6)
Authors: FUCHAROEN, S.; SINGSANAN, S.; SANCHAISURIYA, K.; FUCHAROEN, G.

Evaluation of serum transferrin receptor assay in a centralized iron screening service
pp. 190-194(5)
Authors: O'BROIN, S.; KELLEHER, B.; BALFE, A.; Mc MAHON, C.

Outcome of holistic care in Nigerian patients with sickle cell anaemia
pp. 195-199(5)
Authors: AKINYANJU, O. O.; OTAIGBE, A. I.; IBIDAPO, M. O. O.

An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment
pp. 200-202(3)
Authors: AMIN, C. J.; RABINOWITZ, I.

Plasma cell leukaemia presenting with polyarthralgia and phalangeal lytic lesions
pp. 203-205(3)
Authors: WANDROO, F. A.; MAHENDRA, P.; KHUROO, R. A.; NEILSON, J.

Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility
pp. 206-208(3)
Authors: CURTIN, N. J.; SCHWARER, A. P.

RE: Bain B.J. (2004) Bone marrow biopsy morbidity and mortality: 2002 data. Clinical and Laboratory Haematology26, 315–318
pp. 209-210(2)

Persistent myeloproliferative reaction to intrauterine thalidomide exposure
pp. 211-212(2)

Immature reticulocyte fraction (IRF) monitored in elite athletes during a whole season
pp. 213-214(2)

An unusual cause of thrombocytopenia
pp. 215-216(2)